Ainara Vallejo-Illarramendi

Dr. Ainara Vallejo-Illarramendi

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Schizophrenia Research
Verified
Journal Article
Closed access
APAitor Palomino
Aitor Palomino
AVAinara Vallejo-Illarramendi
Ainara Vallejo-Illarramendi
AGAna González-Pinto
Ana González-Pinto
AAAna Aldama
Ana Aldama
CGCristina González-Gómez
Cristina González-Gómez
Carlos MatuteCarlos Matute
Carlos Matute

1 January 2006 in Neurobiology of Disease
Verified
Journal Article
Closed access
AVAinara Vallejo-Illarramendi
Ainara Vallejo-Illarramendi
MDMaria Domercq
Maria Domercq
FPFernando Pérez-Cerdá
Fernando Pérez-Cerdá
RRRivka Ravid
Rivka Ravid
Carlos MatuteCarlos Matute
Carlos Matute


8 October 2014 in Expert Reviews in Molecular Medicine
Verified
Journal Article
Closed access
AVAinara Vallejo-Illarramendi
Ainara Vallejo-Illarramendi
ITIvan Toral-Ojeda
Ivan Toral-Ojeda
GAGarazi Aldanondo
Garazi Aldanondo
AMAdolfo López de Munain
Adolfo López de Munain
Muscular dystrophies are a group of diseases characterised by the primary wasting of skeletal muscle, which compromises patient mobility and in the most severe cases originate a complete paralysis and premature death. Existing evidence implicates calcium dysregulation as an underlying crucial event in the pathophysiology of several muscular dystrophies, such as dystrophinopathies, calpainopathies or myotonic dystrophy among others. Duchenne muscular dystrophy is the most frequent myopathy in childhood, and calpainopathy or LGMD2A is the most common form of limb-girdle muscular dystrophy, whereas myotonic dystrophy is the most frequent inherited muscle disease worldwide. In this review, we summarise recent advances in our understanding of calcium ion cycling through the sarcolemma, the sarcoplasmic reticulum and mitochondria, and its involvement in the pathogenesis of these dystrophies. We also discuss some of the clinical implications of recent findings regarding Ca2+handling as well as novel approaches to treat muscular dystrophies targeting Ca2+regulatory proteins.

1 July 2001 in Molecular Psychiatry
Verified
Journal Article
Closed access
MMMarcello Melone
Marcello Melone
LVL Vitellaro-Zuccarello
L Vitellaro-Zuccarello
AVAinara Vallejo-Illarramendi
Ainara Vallejo-Illarramendi
APA Pérez-Samartin
A Pérez-Samartin
Carlos MatuteCarlos Matute
Carlos Matute
FCF Conti
F Conti

1 December 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
AGAnia L. Gheyara
Ania L. Gheyara
AVAinara Vallejo-Illarramendi
Ainara Vallejo-Illarramendi
KZKeling Zang
Keling Zang
LMLin Mei
Lin Mei
RSRene St.-Arnaud
Rene St.-Arnaud
LRLouis F. Reichardt
Louis F. Reichardt